SEC Form 4 · accession 0001209191-17-021131
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance McGuire
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 16, 2017 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 15, 2017 | A | 142 | $0.00 | A | 44,556 | D | |
| Class A Common StockF2 | holding | — | — | — | 1,626 | I | By Polaris Venture Management Co. II, L.L.C. | |
| Class A Common StockF3 | holding | — | — | — | 29,117 | I | By Bartlett Partners, LLC | |
| Class B Common StockF3 | holding | — | — | — | 40,000 | I | By Bartlett Partners, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued pursuant to the Director Compensation Plan, effective as of January 2014.
- F2The reporting person is a managing member of Polaris Venture Management Co. II, L.L.C., the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
- F3The reporting person is a managing member of Bartlett Partners, LLC, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein.
Remarks
Exhibit 24: Power of Attorney